MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
    -0.25p
  • 52 Week High: 6.70
  • 52 Week Low: 0.80
  • Currency: UK Pounds
  • Shares Issued: 725.25m
  • Volume: 3,276,128
  • Market Cap: £30.46m
  • RiskGrade: 796
  • Beta: 0.02

Concepta gets ethics committee approval for myLotus UK trials

By Josh White

Date: Thursday 08 Mar 2018

LONDON (ShareCast) - (ShareCast News) - Women's fertility mobile health product developer Concepta announced on Thursday that it has received ethics committee approval to start the user trial for its myLotus product in the UK.
The AIM-traded firm said it engaged UK-based firm, the Clinical Trial Company, to manage the trial, which will be conducted in Rhyl, Wales.

It said the trial was expected to begin in the next month, with 120 women testing the device for ease of use and clarity of instructions.

Patient recruitment for the trial, the process of testing, collecting samples, reporting, result analysis and the final report was expected to take approximately four months.

The results would be included alongside those of the stability trials and the technical file, to support the company's CE-mark.

Concepta also announced that the myLotus product format and the labelling for EU markets had been finalised, and it was currently waiting to undergo the strict audit process of the company's notified body, the BSI.

The audit was expected to be carried out upon completion of the trial in order to obtain final CE-marking.

"We are delighted to announce this important milestone," said CEO Erik Henau.

"Over the last few months, we have dedicated considerable effort to meet the necessary requirements and regulations in order to expedite our CE-marking process.

"We look forward to obtaining this key certification in the coming months, which will allow us to launch our myLotus product in our initial target European markets of the UK, and subsequently, other EU markets as the company grows."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MyHealthchecked Market Data

Currency UK Pounds
Share Price 4.20p
Change Today -0.25p
% Change -5.62 %
52 Week High 6.70
52 Week Low 0.80
Volume 3,276,128
Shares Issued 725.25m
Market Cap £30.46m
Beta 0.02
RiskGrade 796

MyHealthchecked Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Income Not Available
Growth
21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average
22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average

MyHealthchecked Dividends

No dividends found

Trades for 14-May-2021

Time Volume / Share Price
16:35 17,500 @ 4.20p
16:29 9,768 @ 4.29p
16:26 8,062 @ 4.15p
16:25 11,376 @ 4.29p
15:24 186,520 @ 4.20p

MyHealthchecked Key Personnel

CEO Penelope McCormick

Top of Page